SCHEDULE 13G/AAccepted Feb 4, 4:11 PM ET
Cellectar Biosciences, Inc. SCHEDULE 13G/A
Accepted (ET)
4:11 PM
Feb 4, 2026
Filed
Feb 4, 2026
Documents
1
Size
13.3 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.